Announcements Trials
Browse Landscape

Status

Recruiting 4Completed 3Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 23Observational 3

Sponsor

Cancer Type

Endocrine 3

Conditions

Breast Neoplasms 1387Neoplasms 1164Colorectal Neoplasms 624Lung Neoplasms 559Prostatic Neoplasms 538Carcinoma, Non-Small-Cell Lung 443Carcinoma, Hepatocellular 296Stomach Neoplasms 272Pancreatic Neoplasms 270Colonic Neoplasms 264Ovarian Neoplasms 230Head and Neck Neoplasms 228Rectal Neoplasms 221Melanoma 215Multiple Myeloma 202Uterine Cervical Neoplasms 198Lymphoma 195Leukemia 193Precursor Cell Lymphoblastic Leukemia-Lymphoma 191Neoplasm Metastasis 178Carcinoma, Renal Cell 177Esophageal Neoplasms 173Brain Neoplasms 173Leukemia, Myeloid, Acute 158Urinary Bladder Neoplasms 138Recurrence 123Polycystic Ovary Syndrome 122Liver Neoplasms 118Hematologic Neoplasms 117Endometrial Neoplasms 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Observational × Insulinoma × Clear all
NCT07340437 2026-01-15

Clinical Study of 18F-Exendin-4 in Insulinoma

Sichuan Provincial People's Hospital

Completed
20 enrolled
Endocrine

Insulinoma

NCT04741152 2021-02-05

Blinded Resection in Case of the Pancreatic Insulinoma

Vishnevsky Center of Surgery

Completed
197 enrolled
Endocrine

Insulinoma

NCT00937079 2015-01-09

Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients

University Hospital, Basel, Switzerland

Completed
30 enrolled
Endocrine

Hyperinsulinism, Hypoglycemia, Insulinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡